Page last updated: 2024-10-28

go 6976 and Lymphoma, Non-Hodgkin

go 6976 has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Singh, RK1
Verma, PK1
Kumar, S2
Shukla, A1
Kumar, N1
Acharya, A1

Other Studies

1 other study available for go 6976 and Lymphoma, Non-Hodgkin

ArticleYear
Evidence that PKCĪ± inhibition in Dalton's Lymphoma cells augments cell cycle arrest and mitochondrial-dependent apoptosis.
    Leukemia research, 2022, Volume: 113

    Topics: Animals; Apoptosis; Carbazoles; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cycli

2022